Our Blog

But the old guard continues to wield significant power and will be hard pressed to admit defeat, as exemplified by political strategist Bradley Tusk’s continued success. Some might recall Tusk as New York Mayor Bill De Blasio’s biggest critic. Others know him best as Silicon Valley’s favorite political fixer. Teachers’ unions probably remember him comparing them to the NRA. Tusk’s particular brand of politics—lobbying against regulation on behalf of companies he then invests in—in some ways represents the last gasp of corporate control over government that has run rampant since the Reagan era.

Despite pushback from progressives, Ricchetti has continued to hold a powerful advisory position in the Biden White House. His background in corporate lobbying and strong ties to the pharmaceutical industry are deeply troubling signs as the Biden Administration faces enormously consequential decisions about how to end the COVID-19 pandemic.

It is relatively well known, for example, that the Internal Revenue Service has long suffered from under-investments in its budget. Less appreciated, however, are independent facets within the IRS which, rather than being primarily burdened by budget constraints, have simply been forgotten. One such facet is the IRS Oversight Board (IRSOB), which is supposed to provide guidance to the president on the IRS Commissioner and develop long-term strategic plans for the agency. The Board has lacked the five members necessary for a quorum since 2015.

A coalition of 16 organizations called on Secretary of Commerce Gina Raimondo and COVID-19 Response Coordinator Jeffrey Zients to maximally use the executive branch’s existing powers to end the pharmaceutical industry’s stranglehold on supply on COVID-19 vaccines in an open letter today.

The world is currently at an inflection point – Western leaders can choose to continue blocking the TRIPS waiver and lock in a cycle of dependence or empower poorer countries to develop generic vaccines and build infrastructure that will safely put the pandemic behind us. Critiques of the TRIPS waiver claim that most poor countries lack the infrastructure to carry out vaccine operations – a paternalistic view that suggests that manufacturing capacity, supply chain management, and logistics are static in nature. The sooner we act, the more time poorer countries have to begin mobilizing resources needed to make generic vaccine development possible.

On the campaign trail, Biden was reluctant to criticize any aspect of the “Obama-Biden” administration’s record. Since taking office, however, he has made perfectly clear that he is aware of, and has learned from, many of its mistakes. Having watched how an anemic stimulus package in 2009 delivered a slow, faltering recovery and political carnage, the Biden administration chose to go big with its economic response. This initial, consequential departure has earned Biden accolades and prompted a “growing narrative that he’s bolder and bigger-thinking than President Obama” (a narrative Biden reportedly loves). But while Biden may be surpassing Obama legislatively, he is lagging behind him when it comes to the pace of nominations, delaying policy implementation and preventing his administration from reaching its full potential.

With his nomination of Katherine Tai, who has advocated for a worker-centered trade policy, Biden demonstrated his commitment to transforming the trade agenda in the Democratic party. Unfortunately, his choice of Sarah Bianchi to serve as deputy USTR could undermine these efforts:

The world deserves to know exactly who is responsible for the United States not yet supporting a waiver for intellectual property rights on COVID-19 vaccine production.

President Biden’s inaugural annual budget request, which encompasses only discretionary spending (about a third of the federal budget), is a $1.52 trillion proposed investment in the federal government. The rest of the request, to be released later this spring, will include tax reforms and mandatory spending (which includes programs like Social Security, Medicare, and Medicaid) and provide a fuller picture of the administration’s priorities.

As police terror continues to claim the lives of Black Minnesotans, Biden must use all the tools at his disposal to root out police misconduct and deliver on his campaign promises of racial justice. U.S. Attorneys, the local face of the Department of Justice, will be an important institution to leverage. But the remains of Trump’s influence on these offices through acting officials and assistants could thwart the administration’s goals.

President Biden announced last month that he would nominate Todd Kim to be the top environmental lawyer at the Department of Justice. It was a relatively quiet announcement, devoid of much fanfare, compared to the position’s enormous potential to shape environmental and climate policy for years to come.

Hochstein previously served in the Obama State Department, where his job was essentially to secure access to global oil fields on behalf of putatively American multinational Big Oil firms.

Today the Revolving Door Project and People’s Parity Project launched the BigLaw Revolving Door report series to investigate the outsized influence of corporate law firms and their clients on the executive branch and regulatory law spaces. As activists and legal experts continue to urge the Biden Administration to lock BigLaw attorneys, particularly those with large corporate clients, out of the leadership of his Department of Justice, RDP and PPP recognize the importance of exposing the horrific track record of these firms. Through this series, RDP and PPP plan to examine these corporate law firms and their clients more closely and educate the public about this often overlooked system of influence peddling.

As pressure mounts on the United States government to support waiving intellectual property (IP) protections on the COVID-19 vaccines at the World Trade Organization, progressives are closely monitoring the Biden administration’s appointments to agencies that impact intellectual property matters such as the United States Patent and Trademark Office (USPTO).

The prolonged confirmation fights for top Biden nominees proved one thing: Republicans will gleefully and cynically exploit anti-corruption critiques of Biden’s Cabinet for their own political purposes. The President must deny them this potent political weapon by closing corporate America’s revolving door for good.